Skip to main content
Glenmark Pharmaceuticals ltd logo

Glenmark Pharmaceuticals ltd — Investor Relations & Filings

Ticker · GLENMARK ISIN · INE935A01035 LEI · 335800WKECZXIIT9GK20 BSE.NS Manufacturing
Open in API
Filings indexed 1,034 across all filing types
Latest filing 2024-10-30 Regulatory Filings
Country IN India
Listing BSE.NS GLENMARK

About Glenmark Pharmaceuticals ltd

https://glenmarkpharma.com/

Glenmark Pharmaceuticals Ltd. is a research-driven global organization focused on the development, manufacturing, and marketing of generic, specialty, and over-the-counter medicines. The company maintains a specialized focus on therapeutic areas including dermatology, respiratory health, and oncology. It operates a robust research and development pipeline featuring New Chemical Entities (NCEs) and New Biological Entities (NBEs), supported by multiple global R&D centers. Its commercial footprint extends across North America, Europe, and emerging markets. The company is distinguished by its expertise in complex generics and its integrated approach to drug discovery and formulation development. Glenmark utilizes a network of advanced manufacturing facilities to deliver high-quality healthcare solutions globally, emphasizing innovation and accessibility in its product portfolio.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled for November 14, 2024, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2024. It also mentions the closure of the trading window for insiders. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement of a future event related to financial reporting, not the report itself. The document length is only 1988 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-10-30 English
Shareholders meeting
Regulatory Filings
2024-09-27 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges and regulatory bodies, referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the completion of a US FDA inspection at the company's manufacturing facility with no observations. The document is short (2213 characters) and serves as an announcement of a regulatory event rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-09-21 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges and regulatory bodies, referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the U.S. FDA inspection at the company's manufacturing facility and states that Form 483 was issued with zero observations. The document is short (2115 characters) and serves as an announcement of an event rather than a detailed report or financial statement. It does not contain financial data, management discussion, or detailed audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and disclosures that do not fit other specific categories.
2024-09-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a formal communication addressed to stock exchanges and regulatory bodies, specifically mentioning SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the schedule of upcoming Analyst / Institutional Investor meetings, including date, location, and type of meeting. The document does not contain any financial data, results, or detailed reports but is an announcement of planned investor meetings. This fits the description of an Investor Presentation (IP) announcement or schedule notice. Given the content focuses on informing about investor meetings, the best classification is Investor Presentation (IP). The document length is short (2064 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is IP with high confidence.
2024-09-17 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a detailed notice regarding the 46th and 55th Annual General Meetings (AGM) of two companies, Glenmark Pharmaceuticals Limited and RIR Power Electronics Limited. It includes information about the date, time, mode (video conferencing), e-voting procedures, book closure dates, and instructions for shareholders to participate and vote. It also mentions the dispatch of the Notice of AGM and Annual Report for the financial year 2023-24, but the document itself is not the Annual Report or the Notice; rather, it is a newspaper advertisement and official communication about the AGM and related voting information. The document is lengthy (15,000 characters) and contains detailed AGM-related information, but it does not contain financial statements or management discussion. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices related to the AGM. The presence of e-voting details and book closure information further supports this classification. Hence, the filing type code is AGM-R with high confidence.
2024-09-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.